Wuhu Token Sciences (300088) fair value: what the stock is really worth
As of Sep 22, 2026: fair value of Wuhu Token Sciences ¥2.40, price ¥7.26, upside -66.9%, quality 46 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Wuhu Token Sciences for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.
How to read this chart
60‑month range ¥3.81 – ¥13.34 · fair‑value band ¥1.85 – ¥2.85 · the ¥7.26 price screens above the ¥2.40 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.
Follow Wuhu Token Sciences in your weekly email
Every Wednesday you see whether Wuhu Token Sciences is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Wuhu Token Sciences Co., Ltd. engages in the research and development, production, sale, and service of key basic materials and devices in flat panel display devices in China and internationally.
Show more
Wuhu Token Sciences Co., Ltd. engages in the research and development, production, sale, and service of key basic materials and devices in flat panel display devices in China and internationally. It offers thin display panel products, including ultra-thin glass, OLED panel thinning, and TFT-LCD display glass thinning products; touch modules comprising vehicle touch modules, touch sensors, and industrial medical touch modules; and photoelectric materials, such as conductive glasses, color film, ITO coating, AR/IM coating, and other coated products, as well as display modules and automotive module displays. The company was founded in 2000 and is headquartered in Wuhu, China.
Stock analysis
Wuhu Token Sciences (300088) currently trades at ¥7.26, while our model-based Fair Value estimate is ¥2.40, implying the stock looks roughly 202.5% overvalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of ¥3.57 per share, and 3 of the 25 models we run sit above the ¥7.26 price.
Bear case: the Dividend Discount group reads lowest at ¥1.43, and 22 of the 25 models stay below the price. Evidence for this calculation is high.
Scenario range: ¥1.85 (bear) to ¥2.85 (bull), the price of ¥7.26 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 46/100 (below-average quality), in the Technology sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Wuhu Token Sciences reported revenue of 11.6B CNY in FY2025 versus 7.0B CNY in FY2021, a compound +13.3%/yr. Reported net income was 204M CNY in FY2025, compounding −31.1%/yr from FY2021.
Key figures
Market cap 22.0B CNY (≈ $3.3B) · P/E ratio 103.7 · P/S ratio 1.82 · EPS (TTM) ¥0.0700 · Dividend yield 0.7% · Net margin 1.8% · Return on equity 2.3% · Return on assets (EBIT) 4.4%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 38 out of 100 (medium confidence).
What moves the price
The share trades about 38% below its 52-week high and 27% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Technology peers we cover trades at −65% fair-value upside, at −67%, 300088 screens richer than that median.
Fair Value models
Bear ¥1.85Fair Value ¥2.40Bull ¥2.85
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then (¥0.0146 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.62/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+4.7%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+18.3%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+11.1%
Start year 2020 (pandemic). Over 10 years: +11.2% a year
Revenue growth 18 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+26.1%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Basis: EBIT basis.
−13.5%
Earnings growth per share plus dividend.
Earnings per share, growth per year−14.2%
Dividend (yield on the price)0.7%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−25% vs −3%, slowing
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.14% → 4%
Start year 2020 (pandemic)
Growth Forecast
A lot of optimism in the price
The price assumes more growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+78.0%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (China: IMF forecast 1.7% a year to 2030, 1.4% from 2016 to 2025) that is about +75.0% a year for the price.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Electronic Components · 644 stocks
Beats the industry median on 2/15 measures
Overall it trails its industry peers.
Valuation
Quality Score46 · Below median
Fair Value upside−67% · Below median
Profitability
Return on equity (TTM)2% · Below median
Return on assets1% · Below median
Net margin (TTM)2% · Below median
Operating margin (TTM)3% · Below median
Growth and dividend
Revenue growth−12% · Bottom 25%
Dividend yield (TTM)0.7% · Below median
Balance sheet
Debt / equity0.07× · Below median
Valuation Multiplesvs Electronic Components median · lower = cheaper
P/E (TTM)103.7× · Priciest 25%
P/B2.55× · Pricier than median
P/S (TTM)1.96× · Pricier than median
P/FCF93.2× · Priciest 25%
EV/EBITDA19.9× · Pricier than median
PEG0.86× · Cheaper than median
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 0
FUTURE (revenue growth)0· sector 40
PAST (return on equity)9· sector 25
HEALTH (low debt)97· sector 95
DIVIDEND (yield)14· sector 24
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is Wuhu Token Sciences (300088) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of ¥2.40 versus a price of ¥7.26, about −67% upside (overvalued).
What is the fair value of 300088?
Our model-based fair value for Wuhu Token Sciences is ¥2.40 (as of Sep 24, 2026), built from audited fundamentals. The current price: ¥7.26.
What is the quality score of 300088?
Wuhu Token Sciences has a Quality Score of 46/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Wuhu Token Sciences (300088)?
Our model-based price target is the fair value of ¥2.40 (as of Sep 24, 2026) from 25 valuation models. Cautious scenario ¥1.85, optimistic scenario ¥2.85. It is a calculation from audited fundamentals, not an analyst target.
What is the Wuhu Token Sciences stock forecast for 2026?
Our models put fair value at ¥2.40, about −67% upside versus a price of ¥7.26 (overvalued). Cautious scenario ¥1.85, optimistic scenario ¥2.85. The calculation is refreshed regularly with new filings.
What is the revenue of Wuhu Token Sciences (300088)?
Wuhu Token Sciences reported trailing-twelve-month revenue of about 11.2B CNY (latest available figure, as of Sep 24, 2026).
Does Wuhu Token Sciences pay a dividend?
Wuhu Token Sciences currently shows a dividend yield of about 0.69% relative to its recent price (as of Sep 24, 2026).
What growth is priced into Wuhu Token Sciences (300088)?
For today's price to be fair in a discounted-cash-flow model, Wuhu Token Sciences would have to grow free cash flow by +78.0 % per year for five years (discount rate 9.1 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +11.1 % per year. As of Sep 24, 2026.
What discount rate (WACC) does the fair value of 300088 use?
Our models discount Wuhu Token Sciences at 9.1 %: a base by market capitalisation (large), damped by beta 0.69, country premium for China. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Wuhu Token Sciences that is +78.0 % per year a year over ten years, using the same discount rate (9.1 %) and the same formula as our fair value.
How much growth has Wuhu Token Sciences (300088) delivered so far?
Over the past 5 years revenue at Wuhu Token Sciences grew +11.1 % a year. The price currently implies +78.0 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Wuhu Token Sciences (300088) growing?
The median revenue growth in the sector is +8.4 % a year. That is the yardstick for the growth priced into Wuhu Token Sciences (+78.0 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Wuhu Token Sciences (300088)?
The free-cash-flow yield on the price is 0.19 %: that much free cash flow Wuhu Token Sciences produces per unit of market value. When it exceeds the discount rate of our models (9.1 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Wuhu Token Sciences (300088)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Wuhu Token Sciences it is ¥2.40 per share (as of Sep 24, 2026), against a price of ¥7.26. It is the blended result of 25 valuation models (cash flow, earnings, asset, dividend).
Is Wuhu Token Sciences stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 300088 trades above its calculated fair value: price ¥7.26, fair value ¥2.40, a gap of about −67% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 300088?
No. The price is what the market pays today (¥7.26); the fair value is what the company's own numbers justify (¥2.40). For Wuhu Token Sciences the two are ¥4.86 per share apart. That gap is exactly why we show both numbers side by side.
How much is Wuhu Token Sciences worth?
The market values Wuhu Token Sciences at about 22.0B CNY (market capitalisation, as of Sep 24, 2026). Per share that is ¥7.26; our models calculate a fair value of ¥2.40 per share.
What do the bullish and bearish scenarios say about 300088?
Our models span a range for Wuhu Token Sciences: cautious scenario ¥1.85, base ¥2.40, optimistic ¥2.85 per share (as of Sep 24, 2026, price ¥7.26). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 300088?
Wuhu Token Sciences trades at a price-to-earnings ratio of 103.7 (as of Sep 24, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ¥2.40 is built from several models across several years. Other multiples: PEG 0.9, P/B 2.6, P/S 2.0, EV/EBITDA 19.9.
What is the PEG ratio of 300088?
The PEG ratio of Wuhu Token Sciences is 0.86 (P/E divided by earnings growth, as of Sep 24, 2026). That is below 1, so growth is priced more cheaply than the earnings multiple alone suggests.
How solid is the balance sheet of Wuhu Token Sciences (300088)?
Balance-sheet figures for Wuhu Token Sciences (as of Sep 24, 2026): return on equity 2.3%, debt of 0.07 per unit of equity. They feed the Quality Score of 46/100, which measures business quality independently of the share price.
How far is 300088 from its 52-week high?
Wuhu Token Sciences trades at ¥7.26, about 38% below its 52-week high of ¥11.67 and 27% above the low of ¥5.70 (as of Sep 22, 2026). Distance from the high says nothing about value: that is what the fair value of ¥2.40 is for.
Which stocks are comparable to Wuhu Token Sciences?
From the same area (Technology) we also value Amphenol Corporation, Delta Electronics, Inc, Corning Incorporated, Luxshare Precision Industry Co, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Wuhu Token Sciences stock attractive at the current price?
The data as of Sep 24, 2026: price ¥7.26, calculated fair value ¥2.40 (−67%), Quality Score 46/100, from 25 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 300088 calculated?
We run Wuhu Token Sciences through 25 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of ¥2.40, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.1 % above its aggregate fair value. Wuhu Token Sciences itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Wuhu Token Sciences (300088)?
The closing price on Sep 22, 2026 was ¥7.26. Our model-based fair value is ¥2.40, about −67% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Wuhu Token Sciences right now?
The price sits above even our optimistic bull case (¥2.85). The favourable scenario is already priced in. Solid but not exceptional quality (46/100) and above fair value, neither a clear bargain nor a standout compounder.
Where does the earnings growth of Wuhu Token Sciences (300088) come from?
Earnings per share at Wuhu Token Sciences grew +5.8 % a year from 2013 to 2024. Broken into its drivers: revenue per share +14.8 %, EBIT margin −7.8 %, tax rate +1.6 %, residual (interest, one-offs) −1.7 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of Wuhu Token Sciences
How large is the market capitalisation of Wuhu Token Sciences (300088)?
The market capitalisation of Wuhu Token Sciences is 22.0B CNY (≈ $3.3B). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Wuhu Token Sciences (300088)?
The price-to-sales ratio of Wuhu Token Sciences is 1.82 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Wuhu Token Sciences (300088)?
Earnings per share at Wuhu Token Sciences are ¥0.0700 (price ÷ EPS = P/E 103.7). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Wuhu Token Sciences (300088)?
The dividend yield of Wuhu Token Sciences is 0.7% (payout 71.4%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Wuhu Token Sciences (300088)?
The net margin of Wuhu Token Sciences is 1.8% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Wuhu Token Sciences (300088)?
The return on equity (ROE) of Wuhu Token Sciences is 2.3% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Wuhu Token Sciences (300088)?
On an EBIT basis the return on assets of Wuhu Token Sciences is 4.4% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Wuhu Token Sciences (300088)?
The operating margin of Wuhu Token Sciences is 3.2% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Wuhu Token Sciences (300088)?
Revenue at Wuhu Token Sciences is growing −11.8% versus a year earlier (3y avg +18.3%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Wuhu Token Sciences (300088)?
Earnings per share at Wuhu Token Sciences are growing −40.4% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Wuhu Token Sciences (300088) carry?
The net debt of Wuhu Token Sciences is 1.8B CNY (fiscal year 2025, ≈ 49.8 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Wuhu Token Sciences in the live analysis
One click puts Wuhu Token Sciences on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
